Researchers in the Yu lab have developed a method to modify organic molecules, significantly expanding the possibilities for developing and improving drug therapies.
In the Solt lab study, treated animals did not develop high blood sugar indicative of diabetes.
The study from the Karbstein lab sheds light on a key component in the cell’s protein-building process that, if defective, can lead to illness.
Derek Duckett, a TSRI associate professor of molecular therapeutics, is the co-principal investigator for the three-year study.